Medicine & Life Sciences
Non-Small Cell Lung Carcinoma
100%
Neoplasms
70%
Small Cell Lung Carcinoma
61%
Lung Neoplasms
58%
Survival
47%
Pemetrexed
36%
Drug Therapy
31%
Therapeutics
29%
Lung
27%
pazopanib
27%
Carcinoid Tumor
26%
Carboplatin
24%
Malignant Mesothelioma
23%
Maximum Tolerated Dose
22%
Mesothelioma
19%
Genes
18%
Progression-Free Survival
18%
Sorafenib
18%
Confidence Intervals
18%
ErbB Receptors
17%
Protein-Tyrosine Kinases
17%
Anaplastic Thyroid Carcinoma
16%
Pharmacokinetics
15%
Methylation
15%
Cisplatin
15%
Topotecan
15%
Erlotinib Hydrochloride
14%
10-propargyl-10-deazaaminopterin
13%
Biomarkers
13%
vatalanib
12%
Cell Line
12%
Carcinogenesis
12%
Anaplastic Lymphoma Kinase
12%
Clinical Trials
12%
Adenoid Cystic Carcinoma
11%
Mutation
11%
Safety
11%
Smokers
11%
Adenocarcinoma
11%
Paclitaxel
11%
Heterografts
11%
Pancreatic Neoplasms
11%
Fatigue
10%
Neuroendocrine Tumors
10%
Bortezomib
10%
Platinum
10%
Docetaxel
9%
Decitabine
9%
Methyltransferases
9%
DNA
9%